It is well established that cyclooxygenase-2 (COX-2) and the neuronal form of nitric oxide synthase (nNOS) are co-expressed in macula densa cells, and that the expression of both enzymes is stimulated in a number of high renin states. To further explore the role of nNOS and COX-2 in renin secretion, we determined plasma renin activity in mice deficient in nNOS or COX-2. Plasma renin activity was significantly reduced in nNOS -/-mice on a mixed genetic background, and in COX-2 -/-mice on either BALB/c or C57/BL6 congenic backgrounds. In additional studies we accumulated evidence to show an inhibitory influence of
Introduction
Elucidation of the pathways that determine renin secretion is of critical significance in understanding the role of renin-angiotensin system in the control of extracellular volume and blood pressure. Macula densa (MD) control of renin secretion is one of the key mechanisms in the regulation of the renin-angiotensin system. The MD cells are unique cells in the kidney capable of sensing luminal NaCl concentrations and thereby regulating renin secretion rate as well as afferent arteriolar tone. Despite intensive investigation, the molecular mechanisms underlying the sensing function of the MD and its communication with vascular effector cells are still incompletely understood. There is consensus that activation of Na-K-2Cl cotransporter (NKCC2) activity in the apical membrane of the MD cells by high luminal NaCl initiates a chain of intra-and extracellular signals that lead to an inhibition of the release of renin secretion from granular cells. A large body of evidence suggests that prostaglandins (PGs) and nitric oxide (NO) may be part of this mediator chain.
Cyclooxygenase-2 (COX-2), the so-called inducible form of cyclooxygenase, is constitutively expressed in the MD and in adjacent cortical thick ascending limb (cTAL) cells (9, 20, 42) . Its expression increases in various high renin states including salt restriction, NKCC2 inhibition, unilateral renal artery stenosis, or blockade of the renin-angiotensin system (19) . Participation of COX-2-generated prostaglandins in the stimulation of the reninangiotensin system under these circumstances is suggested by the inhibitory effects of COX-2 inhibitors reported by some laboratories (11, 18, 46) . However, evidence to the contrary has also been reported so that a mandatory coupling between a COX-2 product and renin secretion is not universally accepted (24) .
The neuronal form of nitric oxide synthase (nNOS) is abundantly expressed in MD cells (6, 26, 33, 47) , and its expression is stimulated in various high renin states including salt restriction (6, 41, 43) , administration of loop diuretics (6) , or inhibition of the reninangiotensin system (27) , some of the same interventions that augment COX-2 expression.
Direct evidence in support of MD NOS, presumably nNOS, acting as a positive regulator of renin secretion came from studies in the in vitro perfused JGA. In this preparation, administration of L-arginine stimulated renin secretion, and NOS blockers almost completely abolished the stimulation of renin secretion by low NaCl (21) . Results from studies in which NOS inhibitors were administered to whole animals are somewhat less consistent, however, possibly because of the complexities that arise due to the multiple NOS isoforms and cellular sources (23, 40) .
The first purpose of the present studies was to further investigate the roles of nNOS and COX-2 in control of renin secretion using nNOS and COX-2 knockout mice. If NO and prostaglandins are important regulators of renin secretion, plasma renin levels should be markedly affected by the absence of either nNOS or COX-2. A second aim of these studies was to extend knowledge of interactions between nNOS and COX-2 and their bioactive products.
Numerous studies have documented that nitric oxide can stimulate COX-2 activity in a number of different cell types, an effect that may play a role in the upregulation of COX-2 in inflammatory processes (38) . In contrast, it is unclear whether prostaglandins generated by COX-2 affect expression and activity of nNOS. The results of the present study demonstrate that plasma renin levels are significantly reduced in both nNOS and COX-2 knockout mice, and that PGE2 exerts an inhibitory effect on nNOS expression in the macula densa. These results suggest a novel cross-talk between COX-2 and nNOS that may play a critical role in stabilizing renin secretion.
Methods

Materials.
Cell culture media and serum were from Life Technologies, Inc. (Gaithersburg, MD). PGE 2 were from Cayman Chemical (Ann Arbor, MI). Rat nNOS antibody that crossreacts with mouse nNOS was from Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
Primers and fluorescent probes for real time PCR were synthesized by the Sequencing Core Facility at NIDDK, and the probes were HPLC purified by Bioserv Biotechnologies, Ltd (Laurel, MD). Other reagents for real time PCR were from PE Applied Biosystems (Foster City, CA).
Animals. nNOS knockout mice on a mixed 129-C57/BL6 background used in the present study were originally generated by Huang et al. (22) . The NIH subcolony was derived from a heterozygous breeder pair supplied by Dr. O. Carretero (Henry Ford Hospital, Detroit, MI).
Animals of the three genotypes were obtained by brother/sister mating of heterozygous offspring. COX-2 knockout mice on 129-C57/BL6 background were originally generated by Dinchuk et al. (13) , and the breeder pairs were obtained from Jackson Laboratories.
Establishment of COX-2 congenic lines.
Inbred C57/BL6 and BALB/c mice (Jackson Laboratories) were used to generate COX-2 knockout animals on C57/BL6 and BALB/c congenic backgrounds. According to conventional backcross breeding strategy (7, 25) , male heterozygous COX-2 knockout mice were crossed with females of the inbred recipient strains, and this breeding strategy was repeated over 3 years for multiple generations of backcrossing, N9 for BALB/c and N10 for C57/BL6. Congenic homozygous mice were obtained by brother/sister mating of heterozygous animals of the N9 and N10 generation, respectively. Real time RT-PCR. Total RNA was isolated from cells or renal tissues using TRI-zol. One µg of total RNA was denatured at 65 °C for 5 min, and cDNA synthesis was then performed at 42 Immunohistochemistry. Kidneys were perfusion-fixed with 3% paraformaldehyde through an aortic cannula and processed for frozen sectioning. 5-µm cryostat sections were incubated in 0.5 % Triton X-100/PBS for 30 min. After rinsing in PBS unspecific protein binding sites were blocked by a 2 hour incubation with 5% dry milk. The primary antibody (rabbit anti-nNOS, Santa Cruz Biotechnology) was applied in a 1:50 dilution in 5% dry milk over night at room temperature. After rinsing in PBS, signals were detected with a Cy2 labeled secondary antibody, and viewed in an Olympus IMT-2 microscope with fluorescence module.
NADPH diaphorase activity assay. This assay was performed as previously described (5).
Briefly, 5-µm-thick cryostat sections were incubated in 0.1 mol/L phosphate buffer containing nitroblue tetrazolium (NBT), ß-NADPH, and Triton X-100 at 37 °C. The reaction was stopped when the MD signal was clearly distinguishable, and background staining had not yet appeared.
Statistical analysis. Values shown represent means + SE. Statistical analysis was performed
by ANOVA and Bonferroni tests with a p value of less than 0.05 being considered statistically significant.
Results
Plasma renin in nNOS and COX-2 knockout mice. Plasma renin concentration (PRC) was
determined in nNOS -/-mice on a mixed genetic background (nNOS KO), and in two congenic strains of COX-2 -/-mice on BALB/c (COX-2 KO-BALB/c) and C57/BL6 (COX-2 KO-C57/BL6) backgrounds, and their respective wild type control mice fed a normal salt diet. The ages of these mice ranged from 2.5 to 3.5 months. PRC averaged 222.3 ± 66.5 ng ang I/ml hr in wild type whereas a mean value of 31.9 ± 8 ng ang I/ml hr was found in nNOS-/-mice (p=.027). In wild type BALB/c mice PRC was 1600 ± 447 ng ang I/ml hr whereas in COX-2 KO-BALB/c it averaged 131.7 ± 64 ng ang I/ml hr (p=.017). Corresponding values in wild type C57/BL6 and COX-2 KO-C57/BL6 were 1505 ± 475 and 320.2 ± 126 ng ang I/ml hr (p=.042). Differences in baseline values of PRC between the NOS and COX-2 series are most likely due to different housing conditions with NOS mice housed in individual cages and COX-2 mice housed as a group. It seems likely that psychosocial stress levels were higher in the COX-2 mice caged as a group, and that this contributed to the higher levels of PRC.
Despite these differences in baseline values the difference between the genotypes was comparable with PRC in the nNOS-/-being 80.7% lower than in wild type control mice ( Fig.1 A) while COX-2 KO-BALB/c, and COX-2 KO-C57/BL6 (Fig. 1B) (Fig. 2) .
To address the signaling mechanism responsible for the PGE 2 effect in MMDD1 cells, we first examined whether PGE 2 exerts its inhibitory effect on nNOS expression through cAMP. Confluent MMDD1 cells were treated for 30 min with 5 µM PGE 2 in the presence of 10 µM isobutyl methylxanthine (IBMX) to prevent degradation of cAMP. Forskolin served as a positive control for the assay. cAMP content was determined by enzyme immunoassay using acetylation to enhance the sensitivity of the assay. As shown in Fig. 3 , PGE 2 induced a significant increase in cAMP content, as did forskolin, a strong activator of adenyl cyclase.
Like PGE 2 , forskolin was found to significantly suppress nNOS mRNA expression (Fig. 4) .
nNOS expression in the macula densa of COX-2 knockout mice. To further pursue the notion that PGE 2 inhibits nNOS expression, we examined nNOS expression in the macula densa of COX-2 knockout mice using the 129/C57 mixed background strain. To minimize the possibility that changes in nNOS expression might be secondary to the morphological changes that develop in COX-2-deficient animals with time, experiments were performed in mice at early postnatal periods as well as in adults. nNOS mRNA in the kidney was determined by real time RT-PCR. An induction of nNOS mRNA in the whole kidney of COX-2 -/-mice was consistently observed on postnatal day 3 (PND 3) (Fig. 5A ) and PND 10 ( Fig. 5B) . In adult mice (PN60), a significant induction of COX-2 expression mRNA in COX-2 -/-mice was detected only in the renal cortex, but not in outer or inner medulla (Fig. 5C ). Using immunohistochemistry and NADPH diaphorase staining, the increase of both nNOS protein expression ( Fig. 6 ) and NADPH diaphorase activity (Fig. 7) of adult COX-2 -/-mice was localized to the macula densa.
Renal COX-2 expression in nNOS knockout mice.
Considering that NO is a potential regulator of COX-2 expression, we determined whether renal cortical COX-2 expression is altered in nNOS -/-mice using real time RT-PCR. As shown in Fig. 8 , there was no decrease but a slight increase of COX-2 mRNA in renal cortex of nNOS -/-mice compared to wild type controls. However, this increase of COX-2 mRNA did not reach a statistical significance.
Discussion
In Findings in nNOS knockout mice are consistent with earlier evidence in support of the notion that nNOS generated nitric oxide exerts a tonic stimulatory effect on renin release. A special role of nitric oxide in the local regulation of renin secretion by the MD is suggested by the expression of nNOS in MD cells (6, 26, 33, 47) . In addition, nNOS immunoreactivity in MD cells co-localizes with NOS activity as determined by NADPH diaphorase activity using the nitroblue tetrazolium reaction (1). Glucose-6-phosphate dehydrogenase (G-6-PDH), an
NADPH generating enzyme, is more abundant in MD cells than in any other renal epithelial cells (34). Functional evidence for a link between nNOS in MD cells and renin secretion is
provided by the observation that 7-nitroindazole attenuates furosemide-stimulated renin release, presumably predominantly a macula densa-mediated effect, but that it does not change the renin stimulation caused by a reduction in renal perfusion pressure (3, 4). When given chronically, 7-nitroindazole also prevented the stimulation of renin secretion resulting from a 7 day treatment with a low salt diet (3). Furthermore, in an isolated JGA preparation in which nNOS in MD cells is probably the major enzyme responsible for regulated NO release, the stimulation of renin secretion by low NaCl was largely blocked by NOS inhibition (21) .
Despite a large number of studies supporting a tonically stimulatory role of NO in MDdependent renin secretion, contradictory observations have also been reported. For example, in an isolated perfused JGA preparation, elevation of luminal NaCl stimulates NO production measured by DAF-2 fluorescence (28, 31) . This effect of NaCl may be most pronounced at concentrations greater than 60 mM, a range where renin secretion is maximally suppressed (21, 28) . Thus, it is conceivable that the rise of NO is responsible for the failure of high NaCl concentrations to further reduce renin secretion. There is also a limitation of the systemic gene knockout approach in addressing the MD nNOS function given the fact that in addition to the MD cells, nNOS is expressed in other cell types as well, such as renal medullary cells.
Systemic factors unrelated to the MD may also be responsible for the reduction of renin in nNOS ko mice. For example, it has been shown that chronic nNOS inhibition with 7-nitroindazole causes an increase in arterial blood pressure indicating that nNOS deficiency may cause salt retention and extracellular volume expansion (35).
Evidence for a specific role of prostaglandins in MD control of renin secretion has existed even before it was clear that COX-2 was present in the MD with experimental observations supporting an involvement of PGs in the release of renin initiated by the MD input, but not in baroreceptor-mediated renin secretion (16) . The current results showing a significant reduction of plasma renin in COX-2 deficient mice is consistent with a COX-2-generated prostaglandin being involved in the control of renin secretion. Our observations confirm an earlier study in which an about 50% reduction in plasma renin activity was noted in COX-2 knockout mice on a mixed genetic background (12) . The present studies were performed in mice in which the COX-2 deletion had been bred into congenic C57/BL6 and BALB/c backgrounds using backcrossing of the original knockout mice for 9 or 10 generations. Since plasma renin levels were reduced in both congenic strains compared to their wild type controls it appears that differences in genetic background cannot account for the renin phenotype in these mice. These observations complement earlier studies showing that renin mRNA expression and the renin response to salt depletion were reduced in COX-2 knockout mice on a mixed genetic background (49 Like most systems involved in body homeostasis, renin secretion is under the control of several negative feedback inputs that stabilize renin secretion in the face of stimulatory or feedforward effects. For example, it has long been recognized that angiotensin II itself inhibits renin release (17) . Furthermore, more recent studies indicate that angiotensin II inhibits COX-2 activity and the secretion of renin-stimulatory prostaglandins (11, 48) . Finally, angiotensin II deficiency in angiotensinogen knockout mice is associated with an increase in MD nNOS expression suggesting that angiotensin II also downregulates nNOS (26) . In the second part of the present study we report experimental evidence suggesting another negative feedback loop in which PGE 2 generated by COX-2 exerts an inhibitory influence on MD nNOS expression. abnormalities seen in COX-2 knockout mice with aging. In adult 2-month old COX-2-/-mice, the induction of nNOS mRNA was found to be restricted to the cortex, and was not seen in outer or inner medulla, consistent with the MD localization of nNOS. We have previously found that GFR in male COX-2 -/-mice remained normal until 2 months of age and started to decline afterwards whereas a fall in GFR in female COX-2 -/-mice was not demonstrable over a 1 year period (data not shown). Therefore, it is unlikely that the induction of nNOS in the kidney of COX-2 -/-mice is secondary to any morphological or functional abnormalities. Heart Association Grant#0335305N (to T. Yang). 
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